Search Results 771-780 of 16056 for pharmacogenetics

1. Alumni - Genitourinary Pathology Fellowship (Minnesota) - Mayo Clinic College of Medicine & Science

   Program outcomes and additional training opportunities after the Genitourinary Pathology Fellowship Fellowship at Mayo Clinic in Rochester, Minnesota.

2. Chemoradiation With or Without Atezolizumab in Treating Patients With Limited Stage Small Cell Lung Cancer - Mayo Clinic

   Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the ...

3. A Study to Evaluate the Efficacy and Safety of INCB054828 in Subjects With Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement - Mayo Clinic

   The purpose of this study is to evaluate the efficacy and safety of INCB054828 in subjects with myeloid/lymphoid neoplasms with fibroblast growth factor ...

4. Division of Orthopedic Surgery Research - Mayo Clinic Research

   Regenerative medicine in reconstruction of skin and tendon defects. Motion analysis. Spine problems. Scoliosis. Amputation and prosthetics. Biological ...

5. Faculty - Center for Regenerative Biotherapeutics - Mayo Clinic Research

   Faculty members from Mayo Clinic Center for Regenerative Biotherapeutics develop regenerative therapies to rebuild health from within patients' own bodies.

6. Primary Immunodeficiency Clinical Trials

   Common variable immunodeficiency (CVID) is a clinically, genetically and immunologically heterogeneous primary immunodeficiency disease (PID). The goal of this ...

7. W. Charles Huskins, M.D. - Mayo Clinic Faculty Profiles

   Charles Huskins, M.D., is in the prevention and control of health-care-associated infections, particularly those caused by antimicrobial-resistant bacteria, and ...

8. A Study of Everolimus with or without Bevacizumab for Treating Patients with Advanced Kidney Cancer that Progressed after First-Line Therapy - Mayo Clinic

   Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Monoclonal antibodies, such as bevacizumab, can interfere ...

9. A Study of Circulating Tumor DNA as a Biomarker of a Complete Response of Disease for Advanced Gastroesophageal Adenocarcinoma - Mayo Clinic

   The purpose of this study is to evaluate circulating tumor DNA as a potential biomarker for pre-surgery treatment response in patients who have esophageal ...

10. Laboratories - Mayo Clinic Research

    S. Skeletal Development and Regeneration Research: Jennifer J. Westendorf · Statistical Genetics and Genetic Epidemiology: Daniel J. Schaid ...